About Manisha Chatterjee

Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst. Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.


Recent Articles By Manisha Chatterjee

: UPS |  News, Ratings, and Charts

Is UPS Stock a Buy for 2021?

The COVID-19 pandemic led to a big growth in online sales. This, in turn, has enhanced the demand for United Parcel Service’s (UPS) package delivery services. Because the online shopping trend is expected to continue in the post-vaccine world, we think it’s reasonable that UPS should keep thriving. Read ahead to know why it could be wise to bet on the stock now.
: LITE |  News, Ratings, and Charts

2 Lesser-Known 5G Stocks to Add to Your Watchlist

The ongoing rollout of 5G infrastructure globally, along with the increasing availability of compatible mobile devices, makes the prospects bright for companies with exposure to this next generation wireless network standard. However, because most of the well-known players in this space are already trading at lofty valuations, we think it could be wise to bet on lesser-known stocks like Lumentum (LITE) and Cambium Networks (CMBM) that still have plenty of upside. Interested in the details? Read on.
: DHR |  News, Ratings, and Charts

Is Danaher a Good Growth Stock to Buy?

With its diagnostic tests and life sciences research tools, Danaher (DHR) has been playing a significant role in the fight against COVID-19. The company is also strategically positioned to generate significant returns in the post-vaccine world.
: MDT |  News, Ratings, and Charts

Does Medtronic Belong in Your Portfolio?

Medtronic (MDT), an established provider in the medical devices sector, has been improving its financials of late. As U.S. hospitals are now, finally, able to begin shifting their focus (and caregiving) away from COVID-19 and back to other diseases and regular, profitable, surgeries, we believe MDT is strategically positioned to generate healthy returns in the upcoming months. Read on for some details.
: ACN |  News, Ratings, and Charts

Is Accenture Stock a Smart Investment?

The renowned professional services company Accenture (ACN) has recovered significantly from its pandemic lows thanks to its wide market reach and strategic partnerships. Looking forward, we think the company is well positioned to benefit from continued rapid digitalization globally that is expected even in a post-COVID-19 world. Let’s discuss.
: ASML |  News, Ratings, and Charts

ASML Holding: Buy, Sell or Hold?

ASML Holding (ASML) manufactures and sells advanced semiconductor equipment to leading semiconductor companies around the globe. Because the demand for advanced chips is increasing, driven by a rising dependence on technology hardware, we believe ASML is strategically positioned to thrive this year and beyond. Let’s look closer at some details.
: AZN |  News, Ratings, and Charts

Astrazeneca vs. Novavax: Which Vaccine Stock is a Better Buy?

Although the FDA has issued Emergency Use Authorizations (EUAs) only for the COVID-19 vaccines developed by Moderna and Pfizer-BioNTech, several other vaccine candidates are still in development. The vaccines developed by Astrazeneca (AZN) and Novavax (NVAX) are still awaiting EUAs, but they reportedly show much promise in their late-stage clinical trials. So, let’s find out which of these two stocks is a better buy now.
: FB |  News, Ratings, and Charts

Why Facebook is a Better Social Media Stock Than Snap

The coronavirus pandemic is a key element in the accelerating use of social media platforms because it has force people to spend more time at home. With more companies using the social-media channel to advertise their products and services, both Facebook (FB) and Snap (SNAP) should generate significant returns in the near term. But let’s evaluate which of these two stocks is a better buy now.
: YELP |  News, Ratings, and Charts

Yelp vs. Groupon: Which Stock is a Better Buy?

Most retail merchants witnessed a significant decline in their offline sales at the beginning of the COVID-19 pandemic. But because consumers shifted quickly to shopping online, online marketplaces like Yelp (YELP) and Groupon (GRPN) that connect merchants to consumers thrived. And because the online shopping trend is not expected to reverse even in the post-pandemic world, we think YELP and GRPN should continue to thrive. But let’s find out which of these two stocks is a better buy now.
: VIPS |  News, Ratings, and Charts

Alibaba vs. Vipshop: Which Chinese E-Commerce Stock is a Better Buy?

E-commerce platforms received a significant boost from the COVID-19 pandemic, which has forced people to stay home and rely on online platforms for their shopping needs. Because this trend is expected to continue even in the post-pandemic world, we think Alibaba (BABA) and Vipshop (VIPS) should keep thriving. But is VIPS better positioned to ride the wave because BABA is facing regulatory challenges? Let’s find out.
Page generated in 1.3827 seconds.